Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain–Barré syndrome: a case report-Reference-Cited by-同舟云学术

Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain–Barré syndrome: a case report

Published:2016-07-05 Issue:9 Volume:46 Page:875-878
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Jpn. J. Clin. Oncol.

Author:

Tanaka Ryota,Maruyama Hiroshi,Tomidokoro Yasushi,Yanagiha Kumi,Hirabayashi Takumi,Ishii Akiko,Okune Mari,Inoue Sae,Sekine Ikuo,Tamaoka Akira,Fujimoto Manabu

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/46/9/875/7985632/hyw090.pdf

Reference19 articles.

1. Beyond Cancer Vaccines

2. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

3. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

4. Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

5. Nivolumab in Previously Untreated Melanoma withoutBRAFMutation

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach;Expert Opinion on Drug Safety;2024-06-03

2. Immune Checkpoint Inhibitor-Induced Guillain Barre Syndrome: A Single-Institution Case Report and Narrative Review;Cureus;2024-06-01

3. Immunosuppressants against acute kidney injury: what to prefer or to avoid?;Immunopharmacology and Immunotoxicology;2024-03-18

4. Guillain-Barré syndrome and checkpoint inhibitor therapy: insights from pharmacovigilance data;BMJ Neurology Open;2024-03

5. Synergistic effects of immune checkpoints and checkpoint inhibitors in inflammatory neuropathies: Implications and mechanisms;Journal of the Peripheral Nervous System;2023-12-04